Germany: Pharmaceutical Corden Pharma Inaugurates Development Suite for Dosage Products
Corden Pharma announced the completion of its newest early development suite for highly potent, oral solid dosage products in Plankstadt.
Frankfurt/Germany — Plankstadt’s setup has the engineering controls to allow for the production of compounds with various potencies and degrees of containment, the company announced. The manufacturer claims that all steps can be performed, starting from dispensing to film coating, in an engineering controlled environment protecting employees, product and environment.
The new facility allows for the production of small batches, from 100 g to approximately 1,000 g.
The investment in Plankstadt is the latest of several announced investments made by the company during 2017, where further capacity expansion and capabilities were installed in Colorado and Plankstadt to meet growing customer demand.